| 产品详情 |
| Edit |   |
|---|
| Product Name | Fevipiprant |
|---|
| Description | Purity >98%. Fevipiprant is a prostaglandin D2 (PGD2 ) receptor antagonist with a Kd value of 1.14 nM for CRTH2/DP2 and a relatively slow dissociation from this receptor (half-life = 14.4 minutes). It has been shown to inhibit PGD2 -stimulated human eosinophil shape change in whole blood assays (IC50 = 0.44 nM) and to inhibit PGD2 -induced cytokine release in human Th2 cells (IC50 s = 2.56 and 1.4 nM for IL-5 and IL-13, respectively). This compound has undergone testing in a phase II clinical study in uncontrolled allergic asthma. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 2-methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-1 H -pyrrolo[2,3b]pyridine-3-acetic acid, NVP-QAW039, QAW039 |
|---|
| Gene, Accession, CAS # | CAS: 872365-14-5 |
|---|
| Catalog # | LS-H7780 |
|---|
| Price | |
|---|
| Order / More Info | Fevipiprant from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|